Nkarta (NKTX) Revenue & Revenue Breakdown
Nkarta Revenue Highlights
Nkarta Revenue by Period
Nkarta Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | -100.00% |
| 2019-12-31 | $115.39K | -98.24% |
| 2018-12-31 | $6.55M | - |
Nkarta generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Nkarta Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $10.54M | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | -100.00% |
| 2019-12-31 | $385.00 | -200.00% |
| 2019-09-30 | $-385.00 | -116.68% |
| 2019-06-30 | $2.31K | -97.96% |
| 2019-03-31 | $113.08K | - |
Nkarta generated - in revenue during Q1 2024, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Nkarta Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ALEC | Alector | $97.06M | $15.89M |
| RVMD | Revolution Medicines, Inc. Warrant | $11.58M | - |
| KZR | Kezar Life Sciences | $7.00M | - |
| GBIO | Generation Bio | $5.90M | $4.06M |
| IPSC | Century Therapeutics | $2.23M | $771.00K |
| BCEL | Atreca | $770.00K | $80.00K |
| LYEL | Lyell Immunopharma | $130.00K | $3.00K |
| BDTX | Black Diamond Therapeutics | - | - |
| NGM | NGM Biopharmaceuticals | - | $165.00K |
| NKTX | Nkarta | - | - |
| PASG | Passage Bio | - | - |
| MLYS | Mineralys Therapeutics | - | - |
| SANA | Sana Bio | - | - |
| GLUE | Monte Rosa Therapeutics | - | $4.70M |
NKTX Revenue FAQ
What is Nkarta’s yearly revenue?
Nkarta's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. NKTX's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.
What is Nkarta’s quarterly revenue?
Nkarta's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $10.54M, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022). NKTX's quarterly revenue for Q3 2023 was $0, a 100.00% increase from the previous quarter (Q2 2023), and a 0% increase year-over-year (Q3 2022).
What is Nkarta’s revenue growth rate?
Nkarta's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was -100.00%.